A carregar...

Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitor

Rasagiline is a monoamine oxidase type B inhibitor that possesses no amphetamine‐like properties, and provides symptomatic relief in early and late stages of Parkinson's disease (PD). Data in animal models of PD suggest that chronic administration of rasagiline is associated with structural cha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Brain Mapp
Main Authors: Burciu, Roxana G., Ofori, Edward, Shukla, Priyank, Pasternak, Ofer, Chung, Jae Woo, McFarland, Nikolaus R., Okun, Michael S., Vaillancourt, David E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945383/
https://ncbi.nlm.nih.gov/pubmed/27089850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.23213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!